Employers
We offer Rx Report™ pharmacogenomic services to employees as part of their health benefits known as the Personalized Prescription Plan (P3). The P3 plan provides employees and their families with a Rx Report™ pharmacogenomic test designed to personalize their prescription medications. P3 helps both employers and their employees in the following ways:
- Money saved on medication switch
- Less trial and error with new prescription drugs
- Less medication-related absenteeism
- Increased employee productivity
- Fewer employees on disability
- Better employee morale
Statistics and Facts
- 60% of Canadians on prescription medications are unhappy with their treatment plan
- Drug-related negative side effects hospitalize 33,500 Canadians annually, with 1,400 of these cases leading to death
- Canada spends $35 billion2 on prescription medications every year with 41% of Canadians currently on prescription drugs1 and at least 25% on two or more drugs
- According to Statistics Canada and the Conference Board of Canada, full-time employees are absent from work 9.3 days per year on average resulting in a cost to Canadian economy of an estimated $16 billion annually
- Studies have shown that presenteeism (working while sick) can cost a company 7.5 times more than absenteeism, while disability can cost Canadian companies as much as 4% of payroll
- Studies show that employees on high risk medications have 69% more healthcare visits, 3 times more sick days and 4 times more disability claims than those on regular medications
Estimated Savings by Using P3 Services (without considering absenteeism & other healthcare costs)
- Abilify (anti-depressant) – up to $250 per employee/ month
- Doxepin (anti-depressant) – up to $540 per employee/ month
- Capecitabine (chemotherapy) – up to $950 per employee/ month
- VFEND (anti-fungal) – up to $3,000 per employee for 30 days
If you would like to know more about P3 and offer Rx Report™ pharmacogenomic tests as part of your employee benefits, please call us at 1.844.943.0210 or email us at info@personalizedprescribing.com
Ref:
1. Statistics Canada, Catalogue no. 82-003-X • Health Reports, Vol. 25, no. 6, pp. 3-9, June 2014 Prescription medication use by Canadians aged 6 to 79 • Health Matters
2. Canadian Institute for Health Information. Prescribed Drug Spending in Canada, 2017: A Focus on Public Drug Programs. Ottawa, ON: CIHI; 2017.